Antibiotic prophylaxis in total hip arthroplasty: Effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register

Acta Orthopaedica Scandinavica

Volumn 74, Issue 6, 2003, Pages 644-651

  Engesæter, Lars B ^a   Lie, Stein Atle ^b   Espehaug, Birgitte ^a   Furnes, Ove ^a   Vollset, Stein Emil ^b   Havelin, Leif Ivar ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BONE CEMENT; CEFALOTIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLOXACILLIN; COLISTIN; DICLOXACILLIN; ERYTHROMYCIN; GENTAMICIN; PENICILLIN DERIVATIVE;

ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CEMENTATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENDOPROSTHESIS LOOSENING; FEMALE; HIP PROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; OPERATING ROOM; OPERATION DURATION; OSTEOARTHRITIS; REGISTER; REOPERATION; RISK ASSESSMENT; SEX DIFFERENCE; SURGICAL INFECTION; SURVIVAL RATE; SYSTEMIC THERAPY; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME; VISCOSITY;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY, REPLACEMENT, HIP; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; REGRESSION ANALYSIS; REOPERATION;

EID: 0347601726     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016470310018135     Document Type: Article

References (17)

1. Bi Y, Seabold J M, Kaar S G, et al. Adherent endotoxin on orthopedic wear particles stimulates cytokine production and osteoclast differentiation. J Bone Miner Res 2001; 16: 2082-91.
2. Chiu F-Y, Chen C-M, Lin C-F J, Lo W-H. Cefuroxime-impregnated cement in primary total knee arthroplasty. A prospective, randomized study of three hundred and forty knees. J Bone Joint Surg (Am) 2002; 84: 759-62.
3. Clarke M T, Roberts C, Gray J, Keene G S, Rushton N. Detection of bacteria in revision hip replacement surgery by PCR. J Bone Joint Surg (Br) (Suppl. IV) 2001; 83: S393-4.
4. Cox D R. Regression models and life tables (with discussion). J Roy Statist Soc 1972; B34: 187-220.
5. Espehaug B, Engesæter L B, Vollset S E, Havelin L I, Langeland N. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian Arthroplasty Register. 1987-1995. J Bone Joint Surg (Br) 1997; 79: 590-5.
6. Havelin L I, Espehaug B, Lie S A, Engesæter L B, Furnes O, Vollset S E. The Norwegian Arthroplasty Register. 11 years and 73,000 arthroplasties. Acta Orthop Scand 2000; 71: 337-53.
7. Havelin L I, Espehaug B, Furnes O. The Norwegian Arthroplasty Register. Yearbook 2002, Bergen, Norway.
8. Kaplan E L, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-81.
9. Lidgren L. Joint prosthetic infections: A success story. Acta Orthop Scand 2001; 72: 553-6.
10. Malchau H, Herberts P. Prognosis of total hip replacement. Revision and re-revision rate in THR: A revision-risk study of 148,359 primary operations. Scientific exhibition presented at the 65th annual meeting of AAOS, February 19-23, 1998, New Orleans, USA.
11. Santavirta S, Takagi M, Konttinen Y T, Sorsa T, Suda A. Inhibitory effect of cephalotin on matrix metalloproteinase activity around loose hip prostheses. Antimicrob Agents Chemother 1996; 40: 244-6.
12. SPSS Inc. SPSS Advanced Models 9.0. Chicago: SPSS Inc, 1999.
13. Spyniewska G, Lis K, Bilinski P J. Bone turnover markers and cytokines in joint fluid. Analyses in 10 patients with loose hip prosthesis and 39 with coxarthrosis. Acta Orthop Scand 2002; 73: 518-22.
14. van de Belt H, Neut D, Schenk W, van Horn J R, van der Mei H C, Busscher H J. Infections of orthopaedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand 2001; 72: 557-71.
15. Walenkamp G H I M. Prevention of infection in orthopaedic surgery. In: European Instructional Course Lectures (Eds. Thorngren K-G, Soucacos P N, Horan F, Scott J). The British Editorial Society of Bone and Joint Surgery, London 2001; 5: 5-17.
16. Wang M L, Hauschka P V, Tuan R S, Steinbeck M J. Exposure to particles stimulates superoxide production by human THP-1 macrophages and avian HD-IIEM osteoclasts activated by tumor necrosis factor-alpha and PMA. J Arthroplasty 2002; 17: 335-46.
17. Wymenga A, van Horn J, Theeuwes A, Muytjens H, Sloff T. Cefuroxime for prevention of postoperative coxitis. One versus three doses tested in a randomized multicenter study of 2,651 arthroplasties. Acta Orthop Scand 1992; 63: 19-24.